The Stand Up To Cancer Translational Cancer Research Grants represent a new, focused effort to affect advances in cancer research as rapidly as possible through the creation of collaborative, international translational cancer research “Teams.” These Teams are typically smaller than the SU2C Dream Teams, but have the same overarching goal of pursuing the most promising research, accelerating the discovery of new therapies for cancer patients and/or advancing efforts in cancer prevention research.
On August 2, 2012, SU2C announced the first team to receive a Translational Cancer Research Grant in collaboration with the Dutch Cancer Society ( DCS). The grant is supported with money raised in connection with a November 2010 Dutch version of the Stand Up To Cancer televised fundraising event, Sta Op Tegen Kanker, which was broadcasted in the Netherlands under the auspices of the DCS. The Sta Op Tegen Kanker International Translational Cancer Research Team includes researchers from the three largest cancer centers in the Netherlands: the Netherlands Cancer Institute, Erasmus MC and UMC Utrecht. Funding of €1.2 million will support the team over a four-year period.
On April 7, 2014, SU2C announced a second team to receive a Translational Cancer Research Grant, this time in collaboration with the Farrah Fawcett Foundation. The SU2C-Farrah Fawcett Foundation Human Papillomavirus (HPV) Translational Research Team will receive $1.2 million in funding over three years for a project that will focus on patients with HPV-driven cancers (including anal, cervical, and head and neck cancers).
For non-media related SU2C questions, please send an email to SU2C@aacr.org.
Updated: May 2016